CLIA-Waived Drug Testing in Texas: What Employers and Testing Programs Should Know
What CLIA Waived Means — and Why It Matters for Texas Employers
The Clinical Laboratory Improvement Amendments of 1988 — commonly abbreviated as CLIA — established federal standards for laboratory testing performed on human specimens. Under CLIA, certain test systems are classified as waived because they use simple methodologies that carry a low risk of erroneous results and are cleared by the FDA for use outside a clinical laboratory setting.
For Texas employers, the practical implication is significant: a CLIA-waived urine drug test cup or dip card can be administered and read by trained non-laboratory staff at the point of collection — a job site, an HR office, an occupational health clinic, or any other on-site location. No CLIA laboratory certificate is required to operate a waived test system, though testing sites do need to enroll and obtain a Certificate of Waiver from CMS to conduct waived testing in certain settings.
The Two CLIA-Waived Urine Drug Testing Formats
For on-site urine screening, Texas employers have two primary CLIA-waived device formats: the integrated urine drug test cup and the urine drug test dip card. Both formats perform the same fundamental function — immunoassay-based urine drug screening at the point of collection — but they differ in how the specimen is collected and how the test device interacts with that specimen.
Understanding the operational difference between a cup and a dip card is the starting point for matching the right format to your Texas program. Employers who want a fuller comparison of urine and saliva testing formats for Texas workplaces should also read our guide to Texas workplace drug testing laws and considerations in 2026.
Two Formats. Same Goal: Simple On-Site Urine Screening.
Urine Drug Test Cups — The All-In-One Format
The integrated urine drug test cup combines specimen collection and screening in a single device. The donor provides the urine specimen directly into the cup, which contains the immunoassay test strips internally. The collector observes the temperature strip between 2 and 4 minutes after collection — a reading of 90–100°F indicates the specimen falls within the acceptable temperature range — then peels back the result label to read the screening results at the manufacturer-specified result time.
For Texas employers running pre-employment, random, or post-accident testing programs, the cup format reduces the number of handling steps between collection and result. The SAFElife urine cup collection includes CLIA-waived options from 5 through 16 panels, with and without adulterant detection. The Healgen urine cup collection offers additional CLIA-waived cup options across standard panel configurations.
Two SAFElife C-Cup configurations are particularly well-suited for Texas programs requiring broad analyte coverage in a compact, CLIA-waived cup format:
SAFElife 12-Panel C-Cup — Compact Design, CLIA Waived
CLIA Waived · SAFElife · FDA 510(k) · $83.00/2512-panel compact C-Cup. AMP, BAR, BUP, BZO, COC, MAMP, MDMA, MOP, MTD, OXY, PCP, THC. Integrated temp strip. Results at 5 minutes. 25 cups per box. SKU CDOA-6125.
Shop 12-Panel C-CupSAFElife 12-Panel C-Cup + Adulterant Detection, CLIA Waived
CLIA Waived · SAFElife · FDA 510(k)12-panel compact C-Cup with built-in adulterant detection. Same 12-panel analyte coverage plus specimen validity checks. Best for programs where adulterant detection adds a layer of specimen integrity verification.
Shop 12-Panel C-Cup + ADUrine Drug Test Dip Cards — The Flexible Format
A urine drug test dip card is a separate screening device inserted into a urine specimen that has already been collected in a standalone collection cup. The dip card format gives testing programs flexibility — the collection vessel and the screening device are separate, which means organizations can use whatever collection cup they already have on hand and select the dip card panel independently.
For Texas employers who already have a collection cup workflow in place and want to expand their panel without switching cups, dip cards offer a cost-efficient solution. They are also a practical option for programs that test for specialized analytes — such as a dedicated kratom dip card alongside a standard multi-panel cup — without needing to replace the cup entirely. Browse the SAFElife dip card collection for CLIA-waived configurations from 5 through 14 panels.
Panel Selection: Matching Analytes to Your Texas Program
CLIA-waived urine cups and dip cards are available in multiple panel configurations. The right panel for a Texas employer depends on the written drug testing policy, the workforce risk profile, the industry, and any applicable federal or state requirements.
Texas Drug Test Panel Selection Guide
- 5-Panel: AMP, COC, MET/MAMP, OPI, THC — the SAMHSA baseline. Appropriate for general employment programs, high-volume pre-employment screening in retail, staffing, hospitality, and light industrial across Dallas, Houston, San Antonio, and Austin
- 10-Panel: Core 5 + BZO, BAR, MTD, OXY, BUP — broad prescription drug coverage. Best for Texas safety-sensitive roles, construction, oil and gas, transportation, and healthcare where prescription drug impairment is a documented concern
- 12-Panel: 10-panel base + MDMA + one additional analyte. Maximum CLIA-waived analyte coverage for Texas programs seeking comprehensive point-of-care screening in a cup or dip card format
- Fentanyl-inclusive panels: Standard OPI panels do not detect fentanyl. Texas programs concerned about fentanyl exposure should select a cup or dip card configuration that includes a dedicated FTY (fentanyl) analyte
What CLIA Waived Does Not Cover
CLIA-waived urine drug test cups and dip cards provide preliminary screening results. They are not laboratory tests and do not produce confirmed results. For Texas employers participating in the state's Drug-Free Workplace Program or defending an unemployment claim at the Texas Workforce Commission, a preliminary on-site screening result must be confirmed by a certified laboratory using GC-MS or equivalent methodology before it can support an adverse employment action.
The Texas Workforce Commission is explicit on this point: a confirmed laboratory result is part of the documentation required to sustain a drug-related termination at a TWC unemployment hearing. On-site CLIA-waived devices serve a valuable presumptive screening function — they do not replace laboratory confirmation for adverse action purposes.
This content is provided for general informational purposes only and does not constitute legal advice. Any employer or organization considering changes to its workplace or in-house drug screening policies should consult with qualified legal counsel and applicable regulatory authorities before implementing, modifying, or discontinuing any testing program or related procedures.
